REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA
journal contribution
posted on 2023-02-20, 02:01authored byKristen Batich, Duane Mitchell, Patrick Healy, James Herndon, Gloria Broadwater, Gunn Michael, Min-Nung Huang, Kelly Hotchkiss, Luis Sanchez-Perez, Smita Nair, Kendra Congdon, Pam Norberg, Kent Weinhold, Gary Archer, Elizabeth Reap, Weihua Xie, Steven Shipes, Emily Albrecht, Katherine Peters, Dina Randazzo, Margaret Johnson, Daniel Landi, Annick Desjardins, Henry Friedman, Gordana Vlahovic, David Reardon, James Vredenburgh, Darell Bigner, Mustafa Khasraw, Roger McLendon, Eric Thompson, Steven Cook, Peter Fecci, Patrick Codd, Scott Floyd, Zachary Reitman, John Kirkpatrick, Allan Friedman, David M Ashley, John Sampson
REPRODUCIBILITY OF CLINICAL TRIALS USING CMV-TARGETED DENDRITIC CELL VACCINES IN PATIENTS WITH GLIOBLASTOMA